Neurology News

Treatment with tenecteplase in an Australian mobile stroke unit was safe and resulted in improved outcomes compared with alteplase, according to a study published in The Lancet Neurology.

PHILADELPHIA — Diabetes independently increases risk for cognitive decline, yet data from several large trials suggest GLP-1 receptor agonists hold significant promise to mitigate risk for dementia-related events, according to a speaker.

Known for his role as a pilot in “Star Wars,” actor Greg Grunberg has traded in his flight suit to travel cross country to bring awareness to epilepsy care, treatment and patient needs.

Biogen and Happify Health have announced a partnership to provide an artificial intelligence-powered digital solution for people with MS called Kopa, which will offer support for patients through education and engagement.

Long-term use of Xcopri was safe and reduced seizures by more than 90% in adults with uncontrolled focal seizures, according to results of an open-label extension study published in Neurology.

The FDA on June 23 announced a 5-year strategy for improving and extending the lives of people with rare neurodegenerative diseases by advancing development of safe and effective medical products and facilitating access to novel treatments.

Jazz Pharmaceuticals announced it has entered into a licensing agreement with Sumitomo Pharma Co. to develop and commercialize an oral treatment for narcolepsy, idiopathic hypersomnia and other sleep disorders.

AbbVie announced it has submitted a supplemental new drug application to the FDA for Qulipta, a preventive migraine treatment for adults.

In the United States, Indigenous people have the highest risks from natural hazards, according to this year’s Healthiest Communities Rankings report.

DENVER — There may be a link between migraine and clinical endocannabinoid deficiency, a speaker said at the American Headache Society’s annual scientific meeting.